Go to the Globe and Mail homepage

Jump to main navigationJump to main content

(iStockPhoto)
(iStockPhoto)

Valeant to buy some assets of Austrian company Add to ...

Valeant Pharmaceuticals International Inc. said it will buy some assets of Austrian pharmaceutical company Gerot Lannach, to boost its presence in Central and Eastern Europe.

These assets of the company, which makes generic branded drugs, generated revenue of about $55 million in 2011.

Under the deal, Valeant will acquire the assets for less than three times sales, with up to an additional $20 million in milestone payments, the company said in a statement.

More related to this story

Valeant will also enter into a 10-year exclusive supply agreement for the acquired products and will market other Gerot Lannach products in Southeast Asia and Latin America.

The Canadian drug maker has been increasing revenue, mostly through acquisitions, since Biovail Corp., Canada’s largest publicly owned pharmaceutical company, took over U.S.-based Valeant and assumed the Valeant name in September, 2010.

Follow us on Twitter: @GlobeInvestor

In the know

Most popular video »

Highlights

More from The Globe and Mail

Most Popular Stories